Peter Tyrer
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
Papers in
- Oncology 12
- CAR-T cell therapy research 6
- HER2/EGFR in Cancer Research 3
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- A. Ruth Foxwell (6 shared papers)Allan W. Cripps (3 shared papers)Jennelle M. Kyd (3 shared papers)Francesca Zammarchi (11 shared papers)Patrick H. van Berkel (10 shared papers)John A. Hartley (10 shared papers)Narinder Janghra (6 shared papers)Jacqueline I. Keenan (3 shared papers)
- Journals
- Cancer Research (4 papers)Blood (3 papers)Molecular Cancer Therapeutics (2 papers)The International Journal of Biochemistry & Cell Biology (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- United KingdomAustraliaNew Zealand
In The Last Decade
Peter Tyrer
24 papers receiving 620 citations
Peers
Comparison fields: 5 of 87
- Oncology 259
- Immunology 136
- Radiology, Nuclear Medicine and Imaging 138
- Pharmaceutical Science 36
- Microbiology 32
Countries citing papers authored by Peter Tyrer
This map shows the geographic impact of Peter Tyrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Tyrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Tyrer more than expected).
Fields of papers citing papers by Peter Tyrer
This network shows the impact of papers produced by Peter Tyrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Tyrer. The network helps show where Peter Tyrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Tyrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 132 | |
| 2 | 2016 | 98 | |
| 3 | 2005 | 86 | |
| 4 | 2002 | 49 | |
| 5 | 2007 | 40 | |
| 6 | 2014 | 40 | |
| 7 | 2002 | 33 | |
| 8 | Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody-drug Conjugate Targeting AXL-expressing Cancers | 2022 | 29 |
| 9 | The risk of pharmacological dependence with buspirone. | 1985 | 23 |
| 10 | 2011 | 17 | |
| 11 | 2006 | 15 | |
| 12 | 2016 | 14 | |
| 13 | 2016 | 12 | |
| 14 | 2013 | 12 | |
| 15 | 1973 | 10 | |
| 16 | 2024 | 8 | |
| 17 | 2015 | 6 | |
| 18 | 2012 | 6 | |
| 19 | 2010 | 5 | |
| 20 | 2018 | 5 |
About Peter Tyrer
Peter Tyrer is a scholar working on Oncology, Molecular Biology, Neurology, Immunology and Organic Chemistry, having authored 24 papers that have together received 651 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Neuroblastoma Research and Treatments (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers), Cancer therapeutics and mechanisms (4 papers), Escherichia coli research studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Immune Response and Inflammation (3 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Oncology (259 citations), Immunology (136 citations), Radiology, Nuclear Medicine and Imaging (138 citations), Pharmaceutical Science (36 citations) and Microbiology (32 citations). Peter Tyrer has collaborated with scholars based in United Kingdom, Australia and New Zealand. Frequent co-authors include A. Ruth Foxwell, Allan W. Cripps, Jennelle M. Kyd, Francesca Zammarchi, Patrick H. van Berkel, John A. Hartley, Narinder Janghra, Jacqueline I. Keenan, Michael A. Apicella and David G. Williams. Their work appears in journals such as Cancer Research, Blood, Molecular Cancer Therapeutics, The International Journal of Biochemistry & Cell Biology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.